Greenphage
French tech company | Builders Republic
About
Biotech producing precision bacteriophages — natural viruses that selectively destroy specific pathogenic bacteria — as a chemical-free alternative to antibiotics and biocides across human health, animal health, agriculture and food processing, manufactured at its own industrial bacteriophage production unit.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2017
- City
- CLAPIERS
- Region
- Occitanie
- Tracked rounds
- 1
- Amount raised
- 3.5 M€ raised since 2020
Funding rounds
- Series A — 2025
Investors
- ENVIRONNEMENT MASSIF CENTRAL
- GO Capital
- Irdi Capital Investissement
- Sofilaro